Status:
COMPLETED
Probiotics for Reduction Of Markers In Subjects With Allergy
Lead Sponsor:
Rijnstate Hospital
Collaborating Sponsors:
Allergologiepraktijk Arnhem/Radboud/Rijnstate
NIZO Food Research
Conditions:
Hay Fever
Birch Pollen Allergy
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
In vitro studies reveal immunomodulatory effects of probiotic bacteria that are strain-dependent. Differential immunomodulatory in vitro capacities can not be extrapolated directly to in vivo efficacy...
Eligibility Criteria
Inclusion
- birch pollen sensitive subjects
- Positive RAST or intracutane skintest
- age 18-50
- signed informed consent form
Exclusion
- use of probiotics
- known allergy for pets (home setting)
- use of medication influencing the immune system
- use of antibiotics
- lactose intolerance
- pregnancy
- infection
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01137357
Start Date
November 1 2008
End Date
December 1 2008
Last Update
June 4 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Allergologiepraktijk Arnhem/Radboud/Rijnstate
Arnhem, Gelderland, Netherlands, 6824 BJ